Skip to main content
Clinical Trials/JPRN-jRCT1061220099
JPRN-jRCT1061220099
Recruiting
未知

A randomized controlled trial of steroid infusion using a spray tube after ESD for esophageal cancer

Goto Atsushi0 sites100 target enrollmentFebruary 23, 2023

Overview

Phase
未知
Intervention
Not specified
Conditions
esophageal cancer
Sponsor
Goto Atsushi
Enrollment
100
Status
Recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
February 23, 2023
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional
Sex
All

Investigators

Sponsor
Goto Atsushi

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients diagnosed with esophageal cancer or suspected esophageal cancer by endoscopy and biopsy
  • 2\. Esophageal cancer is diagnosed as confined to submucosal infiltration by preoperative endoscopic diagnosis.
  • 3\. Patients who are expected to undergo esophageal ESD for esophageal cancer and resection of 3/4 or more of the luminal circumference but less than the entire circumference
  • 4\. Written consent has been obtained from the patient or legally acceptable representative after receiving a sufficient explanation about study participation.

Exclusion Criteria

  • (1\) Patients with esophageal cancer whose major axis exceeds 5 cm
  • (2\) Patients taking steroids before esophageal ESD
  • (3\) Patients judged by the researcher's doctor to be inappropriate for this study

Outcomes

Primary Outcomes

Not specified

Similar Trials